Dr. William E Gillanders, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Breast Cancer
William E Gillanders, M.D. has run 4 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
William E Gillanders, M.D. has run 2 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center-South County
Clinical Trials William E Gillanders, M.D. is currently running
Personalized Cancer Vaccine
for Bladder Cancer
This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular residual disease. The hypothesis of the trial is that synthetic long peptide personalized cancer vaccines will be safe and capable of generating measurable neoantigen-specific T-cell responses enabling ctDNA clearance. The personalized cancer vaccines are composed of synthetic long peptides corresponding to prioritized cancer neoantigens and will be co-administered with poly-ICLC.
Recruiting
1 award
Phase 1
7 criteria
Endocrine Therapy
for Low-Risk Breast Cancer
This trial is testing if hormone therapy alone can effectively treat breast cancer in women aged 70 or older with certain types of tumors. The therapy works by blocking estrogen, which helps stop cancer cells from growing. Researchers believe this approach could be enough to control the cancer without needing more aggressive treatments.
Recruiting
1 award
Phase 2
7 criteria
More about William E Gillanders, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments William E Gillanders, M.D. has experience with
- Durvalumab
- Personalized Neoantigen DNA Vaccine
- Personalized Cancer Vaccine (PCV)
- Neoantigen Synthetic Long Peptide Vaccine
- Optimized Neoantigen Synthetic Long Peptide Vaccine
- Poly-ICLC
Breakdown of trials William E Gillanders, M.D. has run
Breast Cancer
Lung Cancer
Pancreatic Cancer
Glioblastoma
Skin Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William E Gillanders, M.D. specialize in?
William E Gillanders, M.D. focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are ER positive.
Is William E Gillanders, M.D. currently recruiting for clinical trials?
Yes, William E Gillanders, M.D. is currently recruiting for 4 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that William E Gillanders, M.D. has studied deeply?
Yes, William E Gillanders, M.D. has studied treatments such as Durvalumab, Personalized neoantigen DNA vaccine, Personalized Cancer Vaccine (PCV).
What is the best way to schedule an appointment with William E Gillanders, M.D.?
Apply for one of the trials that William E Gillanders, M.D. is conducting.
What is the office address of William E Gillanders, M.D.?
The office of William E Gillanders, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.